Physician profile
Jonathan Bowman
NPI 1104851294
$53,487.25
in general payments reported to CMS, 2019-2025
40 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $8,902 · 2020: $377 · 2021: $471 · 2022: $904 · 2023: $12K · 2024: $16K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $29K · Food and Beverage: $7,318 · Consulting Fee: $3,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $29,227.77 |
| Food and Beverage | $7,318.48 |
| Consulting Fee | $3,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $1,036.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $29,526.52 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Philips North America LLC | $7,307.35 | 2019-2022 | |
| Medtronic, INC. | $4,486.27 | 2021-2025 | Endurant Iis, Ellipsys Vascular Access System, Venaseal |
| Inari Medical, INC. | $3,435.13 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $3,368.52 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Bard Peripheral Vascular, INC. | $921.04 | 2019-2025 | Crosser Iq, Crosser Iq, Fluency Endovascular Stent Graft |
| Cook Medical LLC | $693.71 | 2019-2025 | Rosen, Zilver Ptx |
| Kci USA, INC. | $600.00 | 2019 | |
| Boston Scientific Corporation | $453.63 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Eluvia, Ekosonic |
| Becton, Dickinson and Company | $450.00 | 2023 | |
| Silk Road Medical, INC. | $323.30 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $314.88 | 2019-2023 | Xarelto |
| Endologix LLC | $307.60 | 2023-2024 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Lemaitre Vascular, INC. | $300.15 | 2020-2025 | Artegraft Vascular Graft |
| E.R. Squibb & Sons, L.L.C. | $205.71 | 2019-2024 | Eliquis |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $160.98 | 2025 | Theragenesis Wound Matrix |
| Medtronic Vascular, INC. | $130.80 | 2019-2020 | |
| Tactile Systems Technology INC | $89.35 | 2019-2021 | |
| Cardiovascular Systems INC. | $67.44 | 2019-2021 | |
| Merit Medical Systems INC | $43.04 | 2025 | Wrapsody Stent Graft, Surfacer Inside-Out Catheter |
| Pfizer INC. | $29.40 | 2021-2024 | |
| Covidien Lp | $25.92 | 2019 | |
| Reprise Biomedical, INC. | $25.20 | 2023 | Miro3d, Miroderm |
| Abbott Laboratories | $25.18 | 2023 | Jeti Peripheral Catheter |
| W. L. Gore & Associates, INC. | $23.43 | 2019 | |
| Penumbra, INC. | $21.13 | 2022 | |
| Asahi Intecc USA, INC. | $20.89 | 2025 | Asahi Peripheral Vascular Wires |
| Solventum Corporation | $19.20 | 2024 | Activ.A.C. |
| Bolton Medical INC | $18.79 | 2024 | Treo Abdominal Stent-Graft System |
| Smith+Nephew, INC. | $16.84 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.76 | 2024 | Nuzyra |
| Cordis US Corp. | $15.36 | 2024 | Radial 360 |
| Biocompatibles, INC. | $14.02 | 2019 | |
| Ethicon US, LLC | $12.90 | 2020 | |
| Bsn Medical INC | $11.62 | 2019 | |
| Reflow Medical INC | $6.19 | 2024 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,916.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$442,721.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.